Login
Orthofix Medical Inc. logo

Orthofix Medical Inc.

ir.orthofix.com

What Do They Do?

Sells spinal and limb-reconstruction devices, biologics and surgical navigation systems to hospitals, surgery centers and healthcare providers.

How Do They Make Money?

Global Spine is the larger business: hospitals pay for implants when used and navigation systems when installed; insurers and government payors reimburse bone-growth devices after fitting and acceptance. Distributors pay when products ship, and biologics marketing fees are earned when the tissue products ship.

revenue
SegmentShareRevenue
Global Spine
Sold outright

84%
FY2022: 77%
Global Limb Reconstruction
Sold outright

16%

Who Are Their Customers?

Hospitals, surgery centers, physicians and healthcare providers are reached through direct sales representatives, sales agents and distributors. Outside the U.S., stocking distributors buy products directly and resell them.

Do Revenues Turn Into Profits?

No. It lost $92.2M in FY2025.

Operating income, FY2025
−10% of revenue
▲ +4% (Loss) vs FY2024 (−$84.6M, −11%)
Net income, FY2025
−11% of revenue
▲ +27% (Loss) vs FY2024 (−$126M, −16%)
Free cash flow, FY2025
0% of revenue
▲ +86% (Loss) vs FY2024 (−$9.1M, −1%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +1%
vs $205.6M in Q3 FY2025
Net income
▲ +73% (Loss)
vs −$22.8M in Q3 FY2025
Global Spine share of revenue vs 83.7% in Q3 FY2025
  • Apr 9, 2026 Orthofix reaffirmed its annual sales, adjusted EBITDA and free cash flow outlook. It expected net sales of $850 million to $860 million, adjusted EBITDA of $95 million to $98 million, and positive free cash flow.

Growing. Revenue grew 77% in 4 years, from $464.5M in FY2021 to $822.3M in FY2025, about 15% a year.

Disc product lines Earlier strategy emphasized expansion in cervical disc replacement, while the latest report says it plans to discontinue artificial cervical and lumbar disc lines and redirect those resources and investments.

Revenue over time
Global Spine Global Limb Reconstruction Global Orthopedics
$1B$500M$0

Who Do They Compete With?

Competes with EBI, Enovis, Bioventus, Theragen, Xstim, Alphatec Spine, Baxter, B. Braun, Brainlab, Cerapedics, Johnson & Johnson, Globus Medical, Highridge Medical, Medtronic, VB Spine, XTANT Medical, Stryker, Smith & Nephew, Paragon 28, and OrthoPediatrics

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support